vs

Side-by-side financial comparison of IRIDEX CORP (IRIX) and Marti Technologies, Inc. (MRT). Click either name above to swap in a different company.

IRIDEX CORP is the larger business by last-quarter revenue ($14.7M vs $14.6M, roughly 1.0× Marti Technologies, Inc.). On growth, Marti Technologies, Inc. posted the faster year-over-year revenue change (63.1% vs -69.7%).

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

The Marti Group is a Swiss construction company, consisting of over 80 subsidiaries, officially owned by Marti Holding AG. Besides Switzerland, they are active in neighboring countries such as Germany and Austria, and also outside of Europe such as China and Chile. The company is known for high-profile public and private sector projects and using innovative technologies. Their areas of expertise include building construction, construction and renovation of tunnels, road construction, hydrauli...

IRIX vs MRT — Head-to-Head

Bigger by revenue
IRIX
IRIX
1.0× larger
IRIX
$14.7M
$14.6M
MRT
Growing faster (revenue YoY)
MRT
MRT
+132.8% gap
MRT
63.1%
-69.7%
IRIX

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
IRIX
IRIX
MRT
MRT
Revenue
$14.7M
$14.6M
Net Profit
Gross Margin
37.2%
49.4%
Operating Margin
-86.1%
Net Margin
Revenue YoY
-69.7%
63.1%
Net Profit YoY
EPS (diluted)
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRIX
IRIX
MRT
MRT
Q4 25
$14.7M
Q3 25
$12.5M
Q2 25
$13.6M
$14.6M
Q1 25
$11.9M
Q4 24
$12.7M
Q3 24
$11.6M
Q2 24
$12.6M
$8.9M
Q1 24
$11.8M
Net Profit
IRIX
IRIX
MRT
MRT
Q4 25
Q3 25
$-1.6M
Q2 25
$-994.0K
Q1 25
$-1.7M
Q4 24
$-834.0K
Q3 24
$-1.9M
Q2 24
$-2.7M
Q1 24
$-3.5M
Gross Margin
IRIX
IRIX
MRT
MRT
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
49.4%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
IRIX
IRIX
MRT
MRT
Q4 25
Q3 25
-11.3%
Q2 25
-6.9%
-86.1%
Q1 25
-1.7%
Q4 24
-3.9%
Q3 24
-16.1%
Q2 24
-20.9%
-204.1%
Q1 24
-28.0%
Net Margin
IRIX
IRIX
MRT
MRT
Q4 25
Q3 25
-12.6%
Q2 25
-7.3%
Q1 25
-14.2%
Q4 24
-6.6%
Q3 24
-16.7%
Q2 24
-21.2%
Q1 24
-29.5%
EPS (diluted)
IRIX
IRIX
MRT
MRT
Q4 25
Q3 25
$-0.09
Q2 25
$-0.06
$-0.26
Q1 25
$-0.10
Q4 24
$-0.05
Q3 24
$-0.12
Q2 24
$-0.16
$-0.38
Q1 24
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRIX
IRIX
MRT
MRT
Cash + ST InvestmentsLiquidity on hand
$6.0M
$4.2M
Total DebtLower is stronger
$83.0M
Stockholders' EquityBook value
$-73.2M
Total Assets
$29.2M
$17.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRIX
IRIX
MRT
MRT
Q4 25
$6.0M
Q3 25
$5.6M
Q2 25
$6.8M
$4.2M
Q1 25
$7.2M
Q4 24
$2.4M
Q3 24
$3.9M
Q2 24
$4.1M
$9.0M
Q1 24
$5.4M
Total Debt
IRIX
IRIX
MRT
MRT
Q4 25
Q3 25
Q2 25
$83.0M
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
$60.2M
Q1 24
Stockholders' Equity
IRIX
IRIX
MRT
MRT
Q4 25
Q3 25
$4.7M
Q2 25
$6.1M
$-73.2M
Q1 25
$852.0K
Q4 24
$2.1M
Q3 24
$2.6M
Q2 24
$4.2M
$-51.2M
Q1 24
$6.5M
Total Assets
IRIX
IRIX
MRT
MRT
Q4 25
$29.2M
Q3 25
$28.4M
Q2 25
$31.6M
$17.2M
Q1 25
$34.2M
Q4 24
$29.1M
Q3 24
$30.2M
Q2 24
$31.2M
$25.0M
Q1 24
$34.1M
Debt / Equity
IRIX
IRIX
MRT
MRT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons